Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Damage from reperfusion: no-reflow phenomenon]

N Lamaida1, V Capuano, M Bifulco

  • 1Ospedale Civile, Battipaglia (Salerno), Reparto di Cardiologia.

Minerva Cardioangiologica
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The dispersal of domestic cats from North Africa to Europe around 2000 years ago.

Science (New York, N.Y.)·2025
Same author

[Diagnostic approach and treatment paradigm in atrophic age related macular degeneration: Recommendations of the France Macula Federation].

Journal francais d'ophtalmologie·2025
Same author

Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists.

European journal of radiology·2025
Same author

Single molecule DNA origami nanoarrays with controlled protein orientation.

Biophysics reviews·2024
Same author

Study of the influence of tributyrin-supplemented diets on the gut bacterial communities of rainbow trout (Oncorhynchus mykiss).

Scientific reports·2024
Same author

Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

Oncogene·2023

Rapid reperfusion therapy for myocardial infarction is key, but biochemical events during reperfusion can limit heart recovery. Understanding these events is crucial for improving patient outcomes after treatments like thrombolysis.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Cell Biology

Context:

  • Myocardial infarction (MI) treatment relies on rapid reperfusion via thrombolysis and/or percutaneous coronary intervention (PCI).
  • Despite restored epicardial blood flow, myocardial tissue perfusion recovery can be incomplete, indicating limitations in reperfusion therapy.
  • Cellular swelling due to ischemia, affecting both damaged and salvageable tissue, contributes to this perfusion defect.

Purpose:

  • To investigate the biochemical and cellular mechanisms that limit myocardial recovery following reperfusion after myocardial infarction.
  • To elucidate the discrepancy between restored epicardial flow and persistent myocardial perfusion defects.
  • To understand the role of endothelial-neutrophil interactions and inflammatory mediators in limiting reperfusion efficacy.

Related Experiment Videos

Summary:

  • Reperfusion injury involves deleterious biochemical events that impede myocardial recovery.
  • Endothelial-neutrophil interactions, mediated by molecules like endothelial leukocyte adhesion molecule 1 (ELAM-1), are upregulated during ischemia.
  • Ischemia depletes anti-inflammatory substances and activates neutrophils, releasing cytotoxic compounds that exacerbate tissue damage.

Impact:

  • Improved understanding of reperfusion injury mechanisms can guide the development of novel therapeutic strategies to enhance myocardial salvage.
  • Identifying key molecular players like ELAM-1 and neutrophil-derived factors may lead to targeted interventions to mitigate reperfusion damage.
  • Optimizing reperfusion protocols by addressing biochemical limitations could improve long-term outcomes for patients with myocardial infarction.